Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Biglycan is an extracellular MuSK binding protein important for synapse stability.

The Journal of neuroscience : the official journal of the Society for Neuroscience | 2012

The receptor tyrosine kinase MuSK is indispensable for nerve-muscle synapse formation and maintenance. MuSK is necessary for prepatterning of the endplate zone anlage and as a signaling receptor for agrin-mediated postsynaptic differentiation. MuSK-associated proteins such as Dok7, LRP4, and Wnt11r are involved in these early events in neuromuscular junction formation. However, the mechanisms regulating synapse stability are poorly understood. Here we examine a novel role for the extracellular matrix protein biglycan in synapse stability. Synaptic development in fetal and early postnatal biglycan null (bgn(-/o)) muscle is indistinguishable from wild-type controls. However, by 5 weeks after birth, nerve-muscle synapses in bgn(-/o) mice are abnormal as judged by the presence of perijunctional folds, increased segmentation, and focal misalignment of acetylcholinesterase and AChRs. These observations indicate that previously occupied presynaptic and postsynaptic territory has been vacated. Biglycan binds MuSK and the levels of this receptor tyrosine kinase are selectively reduced at bgn(-/o) synapses. In bgn(-/o) myotubes, the initial stages of agrin-induced MuSK phosphorylation and AChR clustering are normal, but the AChR clusters are unstable. This stability defect can be substantially rescued by the addition of purified biglycan. Together, these results indicate that biglycan is an extracellular ligand for MuSK that is important for synapse stability.

Pubmed ID: 22396407 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924-12
  • Agency: NCRR NIH HHS, United States
    Id: RR15578
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924-13A1
  • Agency: NIMH NIH HHS, United States
    Id: T32 MH020068
  • Agency: NIAMS NIH HHS, United States
    Id: AR42826
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007601
  • Agency: NICHD NIH HHS, United States
    Id: K12 HD000850-14
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924-14
  • Agency: NICHD NIH HHS, United States
    Id: K12 HD000850
  • Agency: NICHD NIH HHS, United States
    Id: HD00850
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924-15
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924-17
  • Agency: NINDS NIH HHS, United States
    Id: R44 NS045432
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007601-20
  • Agency: NIA NIH HHS, United States
    Id: AG05917
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578
  • Agency: NICHD NIH HHS, United States
    Id: HD23924
  • Agency: Intramural NIH HHS, United States
  • Agency: NIGMS NIH HHS, United States
    Id: T32GM007601
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924-14S1
  • Agency: NIA NIH HHS, United States
    Id: R01 AG005917
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR042826
  • Agency: NINDS NIH HHS, United States
    Id: R44 NS045432-01
  • Agency: NINDS NIH HHS, United States
    Id: U01 NS064295
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-01
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD023924-16
  • Agency: NIA NIH HHS, United States
    Id: R01 AG005917-14

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.